Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy.

Mol Oncol · 2024 · PMC11306511 · PMID 38506049

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Furthermore, si VPS34 significantly induced expression of IRF3 target genes IFNB1 , IRF7 , and CCL5 and showed a clear trend to increase CXCL10 (Fig.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.